Western Blotting Market worth $374.2 Million by 2018, According to a New Study on ASDReports

Wednesday 17 September 2014, Amsterdam

The new report, now available on ASDReports, “Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018” analyzes and studies the major market drivers, threats, opportunities, and challenges.

This report studies the global western blottingmarketover the forecast period of 2013 to 2018.This market wasvaluedat $296.0 millionin 2013 and is poised to grow at a CAGR of 4.8% from 2013 to 2018, to reach $374.2 million by 2018.

The global western blottingmarket is segmented on the basis of products, applications, end users, and geographies. Based on products, the western blottingmarket comprisesof instruments andconsumables. The instruments are further segmented into manual, semi-automated, and automated.

The consumables are divided into kits, reagents, and others (western blotting membranes, blotting papers, and molecular markers). Reagents are further categorized into chromogenic reagents, chemiluminescent reagents, fluorescent reagents, chemifluorescent reagents, and radioisotopic reagents.

On the basis of applications, thewestern blotting market is segmented into disease diagnosis, agriculture, biomedical and biochemical research, and others (QC test in biopharmaceutical industry and biologics).

The market by end users includes pharmaceuticals andbiotechnology industries,research institutes, and diagnostic laboratories.

Based on geography, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest market forwestern blotting, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR inthe coming five years.

Over the years, the demand for western blotting instruments and consumablesis likely to increase owing to a number of factors such as automation in western blottinginstrumentsand rising incidences of Lyme disease and HIV infection. However, the high costs of primary antibodies and the extreme care required to achieve accuracyare the major factors hindering the growth of this market.

Some of the major players in the global western blottingmarket includeBio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.),Sigma-Aldrich Corporation (U.S.), Merck Millipore (U.S.), GE Healthcare (U.K.), PerkinElmer, Inc. (U.S.), Roche Applied Science(U.S.), ProteinSimple, Inc. (U.S.), LI-COR Biosciences (U.S.), and Advansta, Inc. (U.S.).